Safe medication prescribing and monitoring in the outpatient setting.
Shojania
Kaveh G
KG
Clinical Epidemiology Program, Ottawa Health Research Institute, Department of Medicine, University of Ottawa, Ottawa, Ont.
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D017332:Cetirizine / Q000627:therapeutic use; D016903:Drug Monitoring; D005260:Female; D005913:Glipizide / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008297:Male; D008508:Medication Errors; D000077152:Olanzapine; D014859:Warfarin / Q000627:therapeutic use
D018926:Anti-Allergic Agents; D000925:Anticoagulants; D014150:Antipsychotic Agents; D007004:Hypoglycemic Agents; D001569:Benzodiazepines; D014859:Warfarin; D000077152:Olanzapine; D005913:Glipizide; D017332:Cetirizine